ABBOTT INDIA LIMITED
- Country
- 🇮🇳India
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 73K
- Market Cap
- $7.5B
- Website
- http://www.abbott.com
IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice
- First Posted Date
- 2014-04-16
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Abbott
- Target Recruit Count
- 759
- Registration Number
- NCT02115269
- Locations
- 🇰🇿
LLP "State Center for Primary Health Care", Karaganda, Kazakhstan
🇰🇿State communal enterprise " City emergency health care hospital", Shymkent, Kazakhstan
🇺🇦Research facility ID ORG-001000, Mukachevo, Ukraine
Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological Disorder
- Conditions
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2018-12-17
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT02043197
- Locations
- 🇷🇺
Research facility ID ORG-000897, Samara, Russian Federation
🇷🇺Research facility ID ORG-000898, Rostov-on-Don, Russian Federation
🇷🇺Research facility ID ORG-000840, Perm, Russian Federation
A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
- Conditions
- Interventions
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2014-06-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT02009410
- Locations
- 🇪🇸
Site reference no. 112520, Málaga, Spain
🇩🇪Site reference no. 113475, Ulm, Germany
🇩🇪Site reference no. 113456, Bochum, Germany
A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization
- Conditions
- Interventions
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2018-01-02
- Lead Sponsor
- Abbott
- Target Recruit Count
- 1070
- Registration Number
- NCT01850030
- Locations
- 🇦🇹
Site reference no. 113176, Vienna, Austria
🇧🇪Site reference no. 93615, Brussels, Belgium
🇧🇪Site reference no. 93597, Gent, Belgium
Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice
- Conditions
- First Posted Date
- 2013-01-03
- Last Posted Date
- 2015-02-27
- Lead Sponsor
- Abbott
- Target Recruit Count
- 309
- Registration Number
- NCT01759251
- Locations
- 🇺🇦
Research facility ID ORG-000345, Donetsk, Ukraine
🇷🇺Site reference ID 89414, Belgorod, Russian Federation
🇷🇺Site reference ID 89433, Kazan, Russian Federation
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group
- Conditions
- Interventions
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2016-02-19
- Lead Sponsor
- Abbott
- Target Recruit Count
- 108
- Registration Number
- NCT01754714
- Locations
- 🇩🇪
Site Reference ID 93954, Frankfurt, Germany
🇫🇷Site Reference ID 93916, Nice, France
🇫🇷Site Reference ID 93895, Angers, France
Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine Clinical Practice in Russia, Ukraine, Kazakhstan and Uzbekistan
- Conditions
- First Posted Date
- 2012-10-22
- Last Posted Date
- 2015-12-22
- Lead Sponsor
- Abbott
- Target Recruit Count
- 999
- Registration Number
- NCT01711216
- Locations
- 🇷🇺
Site reference ID/Investigaotr# 76705, Tomsk, Russian Federation
🇷🇺Site reference ID/Investigaot# 88513, Voronezh, Russian Federation
🇺🇦Site reference ID/Investigaot# 88056, Lviv, Ukraine
Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) Patients Before and After 8 Weeks Treatment With Mebeverine/Pinaverium Bromide
- Conditions
- First Posted Date
- 2012-09-05
- Last Posted Date
- 2013-09-09
- Lead Sponsor
- Abbott
- Target Recruit Count
- 607
- Registration Number
- NCT01678781
- Locations
- 🇲🇽
Site reference ID/Investigator# 94523, Tampico, Mexico
🇲🇽Site reference ID/Investigaot# 94525, Guadalajara, Mexico
🇵🇱Site Reference ID/Investigator# 85297, Bialystok, Poland
A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease
- First Posted Date
- 2012-08-29
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Abbott
- Target Recruit Count
- 575
- Registration Number
- NCT01674712
- Locations
- 🇨🇿
Site reference ID/Investigator # 102335, Brno, Czech Republic
🇦🇷Site Reference ID/Investigator# 77961, Buenos Aires, Argentina
🇦🇷Site Reference ID/Investigator# 77958, Buenos Aires, Argentina
Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heavy Menstrual Bleeding (HMB) Under Dydrogesterone Treatment
- Conditions
- First Posted Date
- 2012-07-23
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Abbott
- Target Recruit Count
- 210
- Registration Number
- NCT01647360
- Locations
- 🇵🇰
Site reference ID/Investigator# 79836, Islamabad, Federal Capital, Pakistan
🇵🇰Site Reference ID/Investigator# 77674, Karachi, Sindh, Pakistan
🇵🇰Site Reference ID/Investigator# 77675, Karachi, Sindh, Pakistan